Auro Impex & Chemicals Limited (NSE:AUROIMPEX)
India · Delayed Price · Currency is INR 27.85
+1.30 (4.90%)
Sep 11, 2026, 12:41 PM IST
Auro Impex & Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,502 | 2,630 | 3,182 | 2,320 | 1,507 |
| 2,502 | 2,630 | 3,182 | 2,320 | 1,507 | |
Revenue Growth | -4.85% | -17.35% | 37.14% | 53.99% | 104.95% |
Cost of Revenue | 2,291 | 2,429 | 2,954 | 2,124 | 1,392 |
Gross Profit | 211.29 | 200.98 | 227.29 | 196.24 | 114.17 |
Selling, General & Admin | 43.55 | 39.77 | 44.17 | 32.38 | 23.31 |
Other Operating Expenses | 65.6 | 62.22 | 52.71 | 38.47 | 26.68 |
Operating Expenses | 115.19 | 106.64 | 100.45 | 75.72 | 55.22 |
Operating Income | 96.09 | 94.34 | 126.85 | 120.52 | 58.95 |
Interest Expense | -31.8 | -26.66 | -33.37 | -35.26 | -25.78 |
Interest & Investment Income | 4.04 | 2.85 | 2.41 | 1.98 | 1.42 |
Currency Exchange Gain (Loss) | -0.67 | 2.37 | 0.46 | -0.04 | 0.23 |
Other Non Operating Income (Expenses) | -10.34 | -10.89 | -8.55 | -4.37 | -3.61 |
EBT Excluding Unusual Items | 57.32 | 62 | 87.8 | 82.83 | 31.2 |
Gain (Loss) on Sale of Investments | 0.01 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.03 | -0.12 | 0.27 | - | - |
Pretax Income | 57.35 | 61.88 | 88.4 | 82.83 | 31.2 |
Income Tax Expense | 15.76 | 15.58 | 25.7 | 22.84 | 8.2 |
Net Income | 41.59 | 46.3 | 62.71 | 59.99 | 23 |
Net Income to Common | 41.59 | 46.3 | 62.71 | 59.99 | 23 |
Net Income Growth | -10.16% | -26.17% | 4.53% | 160.80% | 154.07% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 9 | 9 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 9 | 9 |
Shares Change | - | 3.53% | 26.98% | - | - |
EPS (Basic) | 3.41 | 3.79 | 5.32 | 6.46 | 2.48 |
EPS (Diluted) | 3.41 | 3.79 | 5.32 | 6.46 | 2.48 |
EPS Growth | -10.05% | -28.76% | -17.65% | 160.64% | 154.07% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 195.45 | -256.44 | -29.15 | -2.29 | -65.76 |
Free Cash Flow Per Share | 16.02 | -21.02 | -2.47 | -0.25 | -7.08 |
Gross Margin | 8.45% | 7.64% | 7.14% | 8.46% | 7.58% |
Operating Margin | 3.84% | 3.59% | 3.99% | 5.20% | 3.91% |
Profit Margin | 1.66% | 1.76% | 1.97% | 2.59% | 1.53% |
Free Cash Flow Margin | 7.81% | -9.75% | -0.92% | -0.10% | -4.37% |
EBITDA | 102.14 | 98.99 | 130.41 | 125.4 | 64.18 |
EBITDA Margin | 4.08% | 3.77% | 4.10% | 5.41% | 4.26% |
D&A For EBITDA | 6.04 | 4.65 | 3.57 | 4.88 | 5.24 |
EBIT | 96.09 | 94.34 | 126.85 | 120.52 | 58.95 |
EBIT Margin | 3.84% | 3.59% | 3.99% | 5.20% | 3.91% |
Effective Tax Rate | 27.47% | 25.18% | 29.07% | 27.57% | 26.28% |
Revenue as Reported | 2,518 | 2,647 | 3,195 | 2,330 | 1,518 |
Advertising Expenses | 0.6 | 0.84 | 4.73 | 1.34 | 0.31 |